LS
Leelyn Smith’s Merck MRK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.68M | Buy |
46,468
+3,661
| +9% | +$290K | 0.6% | 39 |
|
2025
Q1 | $3.84M | Buy |
42,807
+3,685
| +9% | +$331K | 0.68% | 38 |
|
2024
Q4 | $3.89M | Buy |
39,122
+1,286
| +3% | +$128K | 0.69% | 38 |
|
2024
Q3 | $4.3M | Buy |
37,836
+950
| +3% | +$108K | 0.78% | 34 |
|
2024
Q2 | $4.57M | Sell |
36,886
-132
| -0.4% | -$16.3K | 0.88% | 28 |
|
2024
Q1 | $4.88M | Sell |
37,018
-812
| -2% | -$107K | 0.98% | 25 |
|
2023
Q4 | $4.12M | Buy |
37,830
+1,200
| +3% | +$131K | 0.9% | 29 |
|
2023
Q3 | $3.77M | Sell |
36,630
-344
| -0.9% | -$35.4K | 0.92% | 21 |
|
2023
Q2 | $4.27M | Sell |
36,974
-296
| -0.8% | -$34.2K | 1.03% | 20 |
|
2023
Q1 | $3.97M | Buy |
37,270
+905
| +2% | +$96.3K | 1.01% | 22 |
|
2022
Q4 | $4.03M | Buy |
36,365
+1,885
| +5% | +$209K | 1.11% | 21 |
|
2022
Q3 | $2.97M | Sell |
34,480
-6,018
| -15% | -$518K | 1.03% | 21 |
|
2022
Q2 | $3.69M | Buy |
40,498
+341
| +0.8% | +$31.1K | 0.96% | 28 |
|
2022
Q1 | $3.3M | Buy |
40,157
+3,627
| +10% | +$298K | 0.86% | 30 |
|
2021
Q4 | $2.8M | Buy |
36,530
+638
| +2% | +$48.9K | 0.75% | 35 |
|
2021
Q3 | $2.7M | Buy |
35,892
+3,177
| +10% | +$239K | 0.78% | 37 |
|
2021
Q2 | $2.54M | Buy |
32,715
+4,796
| +17% | +$373K | 0.75% | 38 |
|
2021
Q1 | $2.15M | Buy |
27,919
+25,370
| +995% | +$1.96M | 0.64% | 43 |
|
2020
Q4 | $209K | Buy |
2,549
+68
| +3% | +$5.58K | 0.07% | 117 |
|
2020
Q3 | $206K | Buy |
2,481
+123
| +5% | +$10.2K | 0.07% | 116 |
|
2020
Q2 | $182K | Sell |
2,358
-118
| -5% | -$9.11K | 0.08% | 116 |
|
2020
Q1 | $190K | Buy |
2,476
+93
| +4% | +$7.14K | 0.1% | 106 |
|
2019
Q4 | $215 | Buy |
+2,383
| New | +$215 | 0.1% | 108 |
|